The company posted total revenue from operations at ₹4,552 crore, up 13.8% compared to the same period last year
Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business

The company posted total revenue from operations at ₹4,552 crore, up 13.8% compared to the same period last year
Key Takeaways
- Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business.
Read Complete Original Article
Published originally on The Hindu Business Line




